Font Size: a A A
Keyword [Thyroid Cancer]
Result: 161 - 180 | Page: 9 of 10
161. Comparative Analysis Of Clinical Materials Among385Postoperative Thyroid Benign And Malignant Nodules Patients
162. Under Ultrasound Guidance,through The Way Of Percutaneous Radiofrequency Ablation To Treat Cervical Lymph Node Metastasis Which Caused After The Operation For The Thyroid Cancer
163. Roles Of HMGA1in E-cadherin Expression Regulation In Thyroid Cancer Cells
164. The Role Of HMGA1in The Expression Regulation Of Snail In Thyroid Cancer SW579Cells
165. Clinical Application Of CS Combine With LBP Slide-preparing Technique In The Cytological Diagnosis Of Thyroid
166. Research Of The Relation Between Iodine Nutrition Level、sodium/Iodide Transporter And Differentiated Thyroid Carcinoma
167. The Effects And Mechanism Of Curcumin On Thyroid Cancer Metastasis
168. The Expression Profile Of S100A13in Thyroid Carcinoma And The Effects Of S100A13on The Apoptosis Of Human TPC-1Cells
169. FNAB United BRAF Test Study On Clinical Application Research In The Diagnosis Of Thyroid Nodules
170. The Expression And Clinical Significance Of CK19、VEGF And E-cadherin From Papillary Thyroid Carcinoma And Nodular Goiter
171. A Systematic Review Of The Published RCTs Was Used To Compare The Success Rates Of Remnant Thyroid Tissue Ablation Using Low Dose Or High Radioiodine Dose
172. Serum Thyroid Stimulating Hormone Concentration Relationship With Differentiated Thyroid Cancer
173. Value Of Ultrasonic Features Combine With Ultrasound Elastography In The Diagnosis Of Thyroid Cancer
174. HIF-1α Promotes The Invasion And Metastasis Of Thyroid Cancer
175. Outcomc Of Reoperation For Thyroid Cancerxlinical Analysis Of62Cases
176. The Case-control Study On Part Of The Risk Factors Associated With Hashimoto’s Thyroiditis(HT) With Thyroid Cancer
177. Clinical Case Studies Of Thyroid Cancer Combined Hashimoto’s Disease
178. Investigation Of BRAFV600E Gene Mutation And NIS Promoter Methylation In The Papillary Thyroid Cancer
179. The Yiqi Huayu Law Clinical Research In The Treatment Of Differentiated Thyroid Cancer After Surgery
180. Utility Of A PARP-1Inhibitor（PI-34） Combine With131I For Thyroid Cancer Therapy
  <<First  <Prev  Next>  Last>>  Jump to